-+ 0.00%
-+ 0.00%
-+ 0.00%

VTV THERAPEUTICS ANNOUNCES FIRST STUDY PARTICIPANT RANDOMIZED IN CATT1 PHASE 3 TRIAL OF CADISEGLIATIN IN TYPE 1 DIABETES

Reuters·08/07/2025 12:00:02

Please log in to view news